What is the interpretation of a Patient Health Questionnaire-9 (PHQ-9) score of 15, indicating moderately severe depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2025 • View editorial policy

From the Guidelines

A PHQ-9 score of 15 indicates moderately severe depression that requires immediate attention and treatment, as it falls within the moderate to severe symptomatology range, which can significantly interfere with functioning 1.

Interpretation of PHQ-9 Score

The PHQ-9 score of 15 suggests that the patient is experiencing moderately severe depressive symptoms, which can impact their daily life and functioning. According to the guidelines, a score of 15-19 indicates moderate to severe symptomatology, with symptoms interfering moderately to markedly with functioning 2.

I recommend a combination approach including both medication and psychotherapy to address the moderately severe depression. For medication, consider starting with an SSRI such as sertraline (50-200 mg daily), escitalopram (10-20 mg daily), or fluoxetine (20-40 mg daily) 1. These medications typically take 2-4 weeks to show initial effects, with full benefits often appearing after 6-8 weeks. Psychotherapy, particularly cognitive behavioral therapy (CBT) or interpersonal therapy, should be pursued concurrently with 8-12 weekly sessions initially.

Lifestyle Modifications and Follow-up

Regular follow-up is essential, with reassessment of PHQ-9 scores every 2-4 weeks to monitor progress. Lifestyle modifications including regular physical activity (30 minutes of moderate exercise 5 times weekly), consistent sleep patterns, and social engagement can significantly enhance treatment outcomes. If no improvement occurs after 4-6 weeks of treatment, consider adjusting medication dosage, switching to another antidepressant, or adding augmentation therapy.

Special Considerations

Consider special circumstances in the assessment of depressive symptoms, such as culturally sensitive assessments and treatments, tailoring assessment or treatment for those with learning disabilities or cognitive impairments, and being aware of the difficulty of detecting depression in the older adult 1. Assessment of depressive symptoms should be a shared responsibility of the clinical team, with designation of those who are expected to conduct assessments as per scope of practice.

From the Research

Interpretation of PHQ-9 Score

A Patient Health Questionnaire-9 (PHQ-9) score of 15 indicates moderately severe depression, as defined in the study by 3.

PHQ-9 Scoring Categories

The PHQ-9 scores can be categorized as follows:

  • Mild depression: 5
  • Moderate depression: 10
  • Moderately severe depression: 15
  • Severe depression: 20 These categories are based on the study by 3, which validated the PHQ-9 as a measure of depression severity.

Key Points

  • A PHQ-9 score of 15 or higher is associated with moderately severe to severe depression, as noted in the study by 4.
  • The PHQ-9 is a reliable and valid measure of depression severity, as demonstrated in the study by 3.
  • The use of the PHQ-9 in clinical practice can help guide treatment decisions and monitor patient outcomes, as discussed in the studies by 5, 6, and 7.

Clinical Implications

  • A score of 15 on the PHQ-9 indicates that the patient is experiencing moderately severe depression, which may require more intensive treatment or monitoring, as suggested by the study by 5.
  • The PHQ-9 can be used to track changes in depression severity over time, allowing clinicians to adjust treatment plans as needed, as noted in the study by 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.